263 related articles for article (PubMed ID: 8503882)
1. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; Viña J; Estrela JM
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
[TBL] [Abstract][Full Text] [Related]
2. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Kang YJ
Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
[TBL] [Abstract][Full Text] [Related]
3. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
4. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
Lee FY; Allalunis-Turner MJ; Siemann DW
Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
Kang YJ; Enger MD
Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
[TBL] [Abstract][Full Text] [Related]
6. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
Siemann DW; Beyers KL
Br J Cancer; 1993 Dec; 68(6):1071-9. PubMed ID: 8260357
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
Kang YJ
Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
[TBL] [Abstract][Full Text] [Related]
8. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
9. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
Mistry P; Loh SY; Kelland LR; Harrap KR
Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
[TBL] [Abstract][Full Text] [Related]
10. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
11. Glutathione depletion in tissues after administration of buthionine sulphoximine.
Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
[TBL] [Abstract][Full Text] [Related]
12. Suppression of plasma estradiol and progesterone concentrations by buthionine sulfoximine in female rats.
Kang YJ; Uthus EO
Biochem Pharmacol; 1996 Feb; 51(4):567-70. PubMed ID: 8619904
[TBL] [Abstract][Full Text] [Related]
13. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
14. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
15. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
Drew R; Miners JO
Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
[TBL] [Abstract][Full Text] [Related]
16. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
17. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
Jin YZ; Ding L; Shen ZF; Cai RM; Xu LM; Yang JK; Jin XQ; Lu WQ; Xu JF
Chin Med J (Engl); 1992 Aug; 105(8):647-50. PubMed ID: 1458967
[TBL] [Abstract][Full Text] [Related]
18. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
Kang YJ; Emery D; Enger MD
Cell Biol Toxicol; 1991 Jul; 7(3):249-61. PubMed ID: 1933516
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
Palomares T; Bilbao P; del Olmo M; Castro B; Calle Y; Alonso-Varona A
Melanoma Res; 1999 Jun; 9(3):233-42. PubMed ID: 10465578
[TBL] [Abstract][Full Text] [Related]
20. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
Gopalan-Kriczky P; Hiruma S; Lotlikar PD
Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
